{"id":1667,"date":"2020-04-15T09:55:17","date_gmt":"2020-04-14T20:55:17","guid":{"rendered":"https:\/\/clladvocates.nz\/?p=1667"},"modified":"2020-04-15T10:02:12","modified_gmt":"2020-04-14T21:02:12","slug":"new-score-predicts-when-patients-with-cll-should-start-treatment","status":"publish","type":"post","link":"https:\/\/clladvocates.nz\/?p=1667","title":{"rendered":"New Score Predicts When Patients With CLL Should Start Treatment"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243;][vc_column width=&#8221;1\/1&#8243;][vc_custom_heading heading_semantic=&#8221;h1&#8243; text_size=&#8221;h1&#8243;]<\/p>\n<h1 class=\"title\">New Score Predicts When Patients With CLL Should Start Treatment<\/h1>\n<p>[\/vc_custom_heading][vc_column_text]<\/p>\n<div id=\"article-content\">\n<div id=\"pageN_1\" class=\"csdpages\">\n<p>Most patients with\u00a0chronic lymphocytic leukemia\u00a0(CLL) are diagnosed with early stage disease and are managed with active surveillance, but there is much uncertainty over when to start treatment. A simple prognostic model, based on the sum of three routine tests, can now help with this decision, say researchers.<\/p>\n<p>The new score is effective in predicting the amount of time a patient with CLL will likely have before requiring treatment, the team notes. &#8220;Other prognostic scores that are available mostly aim at predicting overall survival of patients who are in need of therapy,&#8221; first author Adalgisa Condoluci, MD, Department of Hematology, Institute of Oncology Research, Bellinzona, Switzerland, told Medscape Medical News<\/p>\n<p><a href=\"https:\/\/aus01.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F928630&amp;data=02%7C01%7CAndrew%40phillipsandpartners.co.nz%7Cbdabfef3088144fa765f08d7e0b3d5ba%7Cee4d68c1e3a046a7a54b4297dbc40a50%7C0%7C0%7C637224935301547150&amp;sdata=iPsb1HYfzeOqE46042THrBdW1iK%2FCvNhW7%2F3HmChM4g%3D&amp;reserved=0\">Continue reading this article on MedScape by registering for free<\/a><\/p>\n<\/div>\n<\/div>\n<p>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Most patients with chronic lymphocytic leukemia (CLL) are diagnosed with early stage disease and are managed with active surveillance, but there is much uncertainty over when to start treatment. A simple prognostic model, based on the sum of three routine tests, can now help with this decision, say researchers<\/p>\n","protected":false},"author":1,"featured_media":1670,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[12,17],"tags":[],"class_list":["post-1667","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-media","category-featured"],"jetpack_featured_media_url":"https:\/\/clladvocates.nz\/wp-content\/uploads\/2020\/04\/research.jpeg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/1667","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1667"}],"version-history":[{"count":1,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/1667\/revisions"}],"predecessor-version":[{"id":1669,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/1667\/revisions\/1669"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/media\/1670"}],"wp:attachment":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1667"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1667"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1667"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}